#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer Primary myelofibrosis Juvenile chronic myelomonocytic leukaemia Arrhythmogenic right ventricular dysplasia Diffuse large B-cell lymphoma Kearns-Sayre syndrome Cataract Cardiac sarcoidosis Chronic kidney disease Hidradenitis Thrombotic thrombocytopenic purpura Hyperoxaluria Mycobacterium abscessus infection Paraganglion neoplasm Immune thrombocytopenia More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Trials in Disease Haemophilia B without inhibitors – Treatment Haemophilia B without inhibitors – Basic Information Fabry’s disease – Trials in Disease Haemophilia B without inhibitors – Diagnostics Hereditary hypophosphataemic rickets – Basic Information Pemphigoid – Treatment Piriformis syndrome – Basic Information Testicular leiomyosarcoma – Treatment Castleman’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Letetresgene Autoleucel NORGESTIMATE Bexotegrast Ponsegromab Bms-986449-03 Diacerein [18F]Alf-Nota-Octreotide Cenobamate L-Lysine Acetate Nivolumab Efavirenz Abc-31-116 Peboctocogene Camaparvovec Trehalose Dihydrate (Ph.eur.) Aciclovir Viltolarsen SAT-3247 OXALATE Apremilast Metyrapone Bp More therapies…

    Learn about Your Condition

    Primary hypogonadism Netherton's syndrome Vulvovaginal pain Gastrectomy Androgenetic alopecia Dyskinesia Altered state of consciousness Myopia Adenosquamous cell lung cancer Monkeypox Endometrial stromal sarcoma Retinopathy of prematurity Chronic granulomatous disease Thyroidectomy Diarrhoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Semaglutide for Patients with Glaucoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on Zoledronic Acid Use After Stopping Denosumab in Women with Postmenopausal Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Zoledronic Acid
    France

  • Study on the Effectiveness of Lenzumestrocel for Treating Knee Cartilage Defects in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cartilage injury
    • Chondropathy
    • Chondroplasty
    Investigated Drugs:
    • Lenzumestrocel
    Czechia

  • Long-term safety study of oral etavopivat tablets in children, adolescents and adults with sickle cell disease or thalassaemia who completed previous etavopivat treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thalassaemia
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    France Germany Greece Italy Spain

  • Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteomyelitis
    • Osteomyelitis acute
    Investigated Drugs:
    • Cefazolin
    • Amoxicillin
    • Cloxacillin
    France

  • Study of Nivolumab, Ipilimumab, and ASTX727 for Melanoma and Lung Cancer Patients Resistant to Anti-PD-1/PD-L1 Therapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Ipilimumab
    Italy
Previous Page
1 … 420 421 422 423 424 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!